المؤلفون: Zaheer J; Division of RI Application, Korea Institute of Radiological and Medical Sciences (KIRAMS), 75 Nowon-ro, Nowon-gu, Seoul 01812, Korea. javeria24@kirams.re.kr.; Radiological and Medico-Oncological Sciences, University of Science and Technology (UST), 75 Nowon-ro, Nowon-gu, Seoul 01812, Korea. javeria24@kirams.re.kr., Kim H; Division of RI Application, Korea Institute of Radiological and Medical Sciences (KIRAMS), 75 Nowon-ro, Nowon-gu, Seoul 01812, Korea. erwin.hyeongi@gmail.com., Lee YJ; Division of RI Application, Korea Institute of Radiological and Medical Sciences (KIRAMS), 75 Nowon-ro, Nowon-gu, Seoul 01812, Korea. yjlee@kirams.re.kr., Lim SM; Division of RI Application, Korea Institute of Radiological and Medical Sciences (KIRAMS), 75 Nowon-ro, Nowon-gu, Seoul 01812, Korea. smlim328@kirams.re.kr., Kim JS; Division of RI Application, Korea Institute of Radiological and Medical Sciences (KIRAMS), 75 Nowon-ro, Nowon-gu, Seoul 01812, Korea. kjs@kirams.re.kr.; Radiological and Medico-Oncological Sciences, University of Science and Technology (UST), 75 Nowon-ro, Nowon-gu, Seoul 01812, Korea. kjs@kirams.re.kr.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2019 Sep 23; Vol. 20 (19). Date of Electronic Publication: 2019 Sep 23.

نوع المنشور: Comparative Study; Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Copper Radioisotopes/*pharmacology , Neoplasms, Experimental/*drug therapy , Radiopharmaceuticals/*pharmacology , Stomach Neoplasms/*drug therapy , Trastuzumab/*pharmacology, Animals ; Cell Line, Tumor ; Dose-Response Relationship, Drug ; Humans ; Mice ; Mice, Nude ; Neoplasms, Experimental/immunology ; Neoplasms, Experimental/pathology ; Stomach Neoplasms/immunology ; Stomach Neoplasms/pathology ; Xenograft Model Antitumor Assays

المؤلفون: Yoon SH; Department of Radiology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Institute of Radiation Medicine, Seoul National University Medical Research Center, Seongnam-si, Korea., Kim YH; Department of Radiology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Institute of Radiation Medicine, Seoul National University Medical Research Center, Seongnam-si, Korea., Lee YJ; Department of Radiology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Institute of Radiation Medicine, Seoul National University Medical Research Center, Seongnam-si, Korea., Park J; Department of Radiology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Institute of Radiation Medicine, Seoul National University Medical Research Center, Seongnam-si, Korea., Kim JW; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si, Korea., Lee HS; Department of Pathology, Seoul National University Bundang Hospital, Seongnam-si, Korea., Kim B; Division of Biomedical Engineering, Hankuk University of Foreign Studies, Yongin-si, Korea.

المصدر: PloS one [PLoS One] 2016 Aug 12; Vol. 11 (8), pp. e0161278. Date of Electronic Publication: 2016 Aug 12 (Print Publication: 2016).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma/*mortality , Carcinoma, Signet Ring Cell/*mortality , Receptor, ErbB-2/*metabolism , Stomach Neoplasms/*mortality , Tomography, X-Ray Computed/*methods , Trastuzumab/*therapeutic use, Adenocarcinoma/diagnostic imaging ; Adenocarcinoma/drug therapy ; Adenocarcinoma/metabolism ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/therapeutic use ; Carcinoma, Signet Ring Cell/diagnostic imaging ; Carcinoma, Signet Ring Cell/drug therapy ; Carcinoma, Signet Ring Cell/metabolism ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; ROC Curve ; Retrospective Studies ; Stomach Neoplasms/diagnostic imaging ; Stomach Neoplasms/drug therapy ; Stomach Neoplasms/metabolism ; Survival Rate